Antithrombogenic effects of calcium channel blockers: Synergism with prostacyclin and thromboxane synthase inhibitors
- 1 June 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 34 (5), 367-378
- https://doi.org/10.1016/0049-3848(84)90241-x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Phospholipid-induced human platelet activation: Effects of calcium channel blockers and calcium chelatorsThrombosis Research, 1983
- Effects of verapamil on platelet aggregation, ATP release and thromboxane generationThrombosis Research, 1983
- Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogsThe American Journal of Cardiology, 1983
- The effects of nifedipine, a calcium antagonist, on platelet functionAmerican Heart Journal, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Inhibition of human platelet function by verapamilThrombosis Research, 1982
- Inhibition of Platelet Aggregation by VerapamilJournal of Cardiovascular Pharmacology, 1982
- In vitro effect of the coronary vasodilator diltiazem on human and rabbit plateletsThrombosis Research, 1978
- Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane A2Prostaglandins, 1977
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977